Elucidation of molecular mechanism of endochondral ossification targeting novel therapeutic strategy for skeletal dysplasia
Elucidation of molecular mechanism of endochondral ossification targeting novel therapeutic strategy for skeletal dysplasia
批准号:
17590959
负责人:
YASODA Akihiro
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Natriuretic peptide family consists of three endogenous ligands, ANP, BNP and CNP, and their membranous guanylyl cyclase receptors, GC-A and GC-B. We have shown that CNP-GC-B system is a strong stimulator of endochondral bone growth and that disturbed endochondral bone growth in mice model of achondroplastic with an activated FGFR3 in cartilage is greatly improved by activation of CNP-GC-B system. As for the mechanism, CNP/GC-B/cGMP restores the decreased cartilaginous matrix synthesis by inhibiting activation of MAPK pathway of FGF signaling.In this project, further we investigated the intracellular signaling interaction between CNP-GC-B system and FGF system in cartilage. First we showed that FGF system stimulates both MAPK and STAT1 pathway and that CNP-GC-B system does not interfere to STAT1 pathway. We also showed that FGF signaling stimulates PI3/PKB pathway to which CNP-GC-B system interferes, and that PI3/PKB system is suppressed under the condition with heparin. On the other hand, activation of FGF pathway decreased the production of cGMP, the second messenger of CNP-GC-B system, dose-dependently. These results exhibit the reciprocal regulation of CNP-GC-B system and FGF system in cartilage.Next we investigated local natriuretic peptide clearance system in cartilage by using fetal mice tibial organ culture system. Selective agonist for natriuretic peptide clearance receptor, C-ANF (4-23), elongated cultured fetal tibiae dose-dependently, and accordingly, we concluded that local natriuretic peptide clearance system works as one of the regulator of CNP-GC-B system in cartilage.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Expression of the aderenomedullin gene in adipose tissue.
脂肪组织中腺髓质素基因的表达。
DOI:
--
发表时间:
2005
期刊:
Regul Pept 132
影响因子:
--
作者:
[Nambu T, Arai H, Komatsu Y, Yasoda A, Moriyama K, Kanamoto N, Itoh H, Nakao K]
通讯作者:
Nakao K
DOI:
10.1007/s00198-005-1923-3
发表时间:
2006-01-01
期刊:
OSTEOPOROSIS INTERNATIONAL
影响因子:
4
作者:
[Natsui, K, Tanaka, K, Nakao, K]
通讯作者:
Nakao, K
Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription.
抗甲状腺药物抑制甲状腺激素受体介导的转录。
DOI:
--
发表时间:
2006
期刊:
J Clin Endocrinol Metab. 92・3
影响因子:
--
作者:
[Moriyama K, Tagami T, Usui T, Naruse M, Nambu T, Hataya Y, Kanamoto N, Li YS, Yasoda A, Arai H, Nakao K]
通讯作者:
Nakao K
Complementary antagonistic actions between C-Type natriuretic peptide and MAPK pathway through FGFR-3 in ATDC5 Cells.
ATDC5 细胞中 C 型利尿钠肽和 MAPK 通路通过 FGFR-3 的互补拮抗作用。
DOI:
--
发表时间:
2005
期刊:
Bone 36
影响因子:
--
作者:
[Ozasa A, Komatsu Y, Yasoda A, Miura M, Nakatsuru Y, Sakuma Y, Arai H, Itoh N, Nakao N]
通讯作者:
Nakao N
Translational research for novel therapeutic strategy for skeletal dysplasias
-
批准号:21591176
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:YASODA Akihiro
-
依托单位:
Translational Research of the CNP/GC-B system for Skeletal dysplasias
-
批准号:19591075
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:YASODA Akihiro
-
依托单位:
海外基金